Cargando…

The importance of early detection of calcifications associated with breast cancer in screening

PURPOSE: The aim of this study was to assess how often women with undetected calcifications in prior screening mammograms are subsequently diagnosed with invasive cancer. METHODS: From a screening cohort of 63,895 women, exams were collected from 59,690 women without any abnormalities, 744 women wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mordang, J. J., Gubern-Mérida, A., Bria, A., Tortorella, F., Mann, R. M., Broeders, M. J. M., den Heeten, G. J., Karssemeijer, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790861/ https://www.ncbi.nlm.nih.gov/pubmed/29043464 http://dx.doi.org/10.1007/s10549-017-4527-7

Ejemplares similares

Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study
por: Vreemann, Suzan, et al.
Publicado: (2019)

The frequency of missed breast cancers in women participating in a high-risk MRI screening program
por: Vreemann, S., et al.
Publicado: (2018)

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers
por: Vreemann, Suzan, et al.
Publicado: (2018)

Increasingly strong reduction in breast cancer mortality due to screening
por: van Schoor, G, et al.
Publicado: (2011)

Influence of breast compression pressure on the performance of population-based mammography screening
por: Holland, Katharina, et al.
Publicado: (2017)

Consequences of digital mammography in population-based breast cancer screening: initial changes and long-term impact on referral rates
por: Bluekens, Adriana M. J., et al.
Publicado: (2010)

Is de-escalation of treatment by omission of radiotherapy associated with fear of cancer recurrence in women with early breast cancer? An exploratory study
por: Stafford, Lesley, et al.
Publicado: (2023)

Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform
por: Howard, Frederick M., et al.
Publicado: (2022)

Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
por: Wardell, Suzanne E., et al.
Publicado: (2019)

Volumetric Breast Density Estimation from Full-Field Digital Mammograms: A Validation Study
por: Gubern-Mérida, Albert, et al.
Publicado: (2014)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease
por: Adhikary, Sabina, et al.
Publicado: (2020)

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
por: Engstrøm, M. J., et al.
Publicado: (2013)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
por: Jansen, M. P. H. M., et al.
Publicado: (2011)

MUTYH gene variants and breast cancer in a Dutch case–control study
por: Out, Astrid A., et al.
Publicado: (2012)

Promoter hypermethylation profiling of distant breast cancer metastases
por: Schrijver, Willemijne A. M. E., et al.
Publicado: (2015)

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI
por: Vreemann, Suzan, et al.
Publicado: (2018)

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
por: Green, Andrew R., et al.
Publicado: (2016)

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
por: Eustace, A. J., et al.
Publicado: (2021)

Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients
por: Mast, Mirjam E., et al.
Publicado: (2014)

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

Enrichment of high-grade tumors in breast cancer gene expression studies
por: van Seijen, M., et al.
Publicado: (2017)

Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
por: Savci-Heijink, C. D., et al.
Publicado: (2019)

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
por: Wirtz, Ralph M., et al.
Publicado: (2016)

CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes
por: Kerekes, Daniel, et al.
Publicado: (2017)

CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment
por: Beelen, K., et al.
Publicado: (2013)

Natural history of age-related lobular involution and impact on breast cancer risk
por: Radisky, Derek C., et al.
Publicado: (2016)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

Geographic variation in volumetric breast density between screening regions in the Netherlands
por: van der Waal, Daniëlle, et al.
Publicado: (2015)

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma
por: Vangangelt, K. M. H., et al.
Publicado: (2017)

Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development
por: Pillai, Sreeraj G., et al.
Publicado: (2015)

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

Contrast enhanced mammography in breast cancer surveillance
por: Elder, Kenneth, et al.
Publicado: (2023)

Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer
por: Dix-Peek, Thérèse, et al.
Publicado: (2023)

The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ
por: Al-Kawaz, Abdulbaqi, et al.
Publicado: (2021)

Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer
por: Abdullah, Nurul A, et al.
Publicado: (2021)

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
por: Moreno-Aspitia, Alvaro, et al.
Publicado: (2013)

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers
por: Ahmad, Dena A. J., et al.
Publicado: (2016)

Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2020)

Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
por: Anderson, Richard A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_haa4q5i2eksphr0vncpksjur46